Lyka Labs Limited (NSE:LYKALABS)
113.01
+0.78 (0.70%)
Jun 20, 2025, 3:29 PM IST
Lyka Labs Revenue
In the fiscal year ending March 31, 2025, Lyka Labs had annual revenue of 1.38B INR with 30.43% growth. Lyka Labs had revenue of 334.29M in the quarter ending March 31, 2025, with 46.90% growth.
Revenue
1.38B
Revenue Growth
+30.43%
P/S Ratio
2.89
Revenue / Employee
3.27M
Employees
423
Market Cap
4.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.38B | 323.12M | 30.43% |
Mar 31, 2024 | 1.06B | 167.66M | 18.75% |
Mar 31, 2023 | 894.17M | -950.50M | -51.53% |
Mar 31, 2022 | 1.84B | 1.16B | 169.25% |
Mar 31, 2021 | 685.11M | 118.05M | 20.82% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
Lyka Labs News
- 2 months ago - Lyka Labs secures patent for Pregabalin Gel 8% to treat diabetic neuropathic pain - Business Upturn